Condition
Follicular Lymphoma Grade 3A clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Follicular Lymphoma Grade 3A clinical trials that are recruiting, at sites in 2 countries (most in Taiwan (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
XNW5004 tablets for relapsed or refractory EZH2 wild-type follicular lymphoma
This trial will try XNW5004 tablets in adults with relapsed or refractory EZH2 wild-type follicular lymphoma who have had at least three prior systemic treatments to see if the drug shrinks tumors and is tolerable.
-
Long-term follow-up of gene-edited immune cell therapy for lymphoma
This study is checking how safe and effective a gene-edited immune cell therapy is for people with lymphoma who received the treatment in the past.
Related topics
Quick answers
How many Follicular Lymphoma Grade 3A clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Taiwan (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.